Toronto Blue Jays rookie pitcher Trey Yesavage resumed flat-ground throwing Tuesday as part of his recovery from left-knee meniscus surgery [1, 2].
The progress marks a critical step in the rehabilitation of the 23-year-old [1] right-handed pitcher. His return is vital for a rotation seeking stability and depth during the final stretch of the campaign.
Yesavage is conducting his rehabilitation at the Blue Jays player-development complex in Dunedin, Florida [2, 3]. The flat-ground program is designed to rebuild arm strength and maintain mechanical consistency while the knee continues to heal [1, 2].
The resumption of throwing comes approximately one week [1] after the pitcher underwent surgery on his left knee [2]. While some early reports suggested surgery was only a possibility pending MRI results, subsequent updates confirmed the procedure took place [2, 3].
Team officials are working toward a target return timeframe before the end of the regular season [1]. The progression from flat-ground work to mound sessions will depend on how the knee responds to the increased stress of pitching mechanics.
Yesavage entered the league as a highly touted rookie, and his absence has left a gap in the Toronto pitching staff. The team's medical staff in Florida will monitor his stability and pain levels daily as he advances through the throwing progression [2, 3].
If the current timeline holds, Yesavage could provide the Blue Jays with an additional arm for the final weeks of the season. The focus remains on a gradual increase in intensity to avoid setbacks with the meniscus [1, 2].
“Trey Yesavage resumed flat-ground throwing Tuesday as part of his recovery from left-knee meniscus surgery.”
The rapid transition to a throwing program suggests the Blue Jays are aggressive in their timeline for Yesavage's return. Because pitchers rely heavily on their lead leg for stability and power, any meniscus issue can jeopardize velocity and command. A successful return before the season ends would not only bolster the current roster but provide the team with critical data on his health heading into the next year.
